Scale AI's Wang Brings Meta Knowledge of What Everyone Else is Doing
Scale AI co-founder Alexandr Wang is such an enthusiastic networker that his former roommate — OpenAI Chief Executive Officer Sam Altman — once jokingly told him to tone it down a bit.
Fortunately for Wang, he ignored the advice. Last week, the 28-year-old parlayed his ability to cultivate influential relationships into a $14.3 billion investment from Meta in Scale, and a new job for himself in Meta's 'superintelligence' group, reporting to CEO Mark Zuckerberg. His own cash and equity in the deal is worth more than $5 billion, according to the Bloomberg Billionaires Index. What Meta is buying: the one guy who knows what everyone else in the AI industry is doing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
28 minutes ago
- Washington Post
Biotech pauses trial after second patient death linked to gene therapy
Biotech firm Sarepta Therapeutics said that a second patient died after receiving its gene therapy to treat Duchenne muscular dystrophy, the latest drug to draw scrutiny after winning fast regulatory approval. The Cambridge, Massachusetts-based firm's stock lost more than 40 percent of its value Monday, a day after disclosing the death and announcing that it would temporarily stop shipping the treatments for certain patients, and pause a clinical trial, while it evaluates its protocols.
Fast Company
30 minutes ago
- Fast Company
Eli Lilly is making it cheaper and easier to buy high-doses of blockbuster weight loss drug Zepbound
Eli Lilly announced on Monday it will soon make the two highest-doses of its popular weight-loss drug Zepbound available for self-paying customers on its website. Starting in August, 12.5 mg and 15 mg single-doses will be added to the company's website, effectively making all Zepbound doses available for $499 a month, or less. Unlike the pen form sold at pharamcies like Walgreens and CVS, the drug will be available in vial form through its LillyDirect self-pay pharmacy, which will require patients to draw their own shots into a syringe rather than have them prefilled. The drug will be to any eligible adult with obesity and a valid prescription regardless of insurance coverage. Health care providers and doctors can start prescribing the higher doses on July 7, according to Lilly. Zepbound is an injectable prescription medicine that belongs to a class of drugs known as GLP-1 receptor agonists originally developed for type 2 diabetes, that may help adults for treating obesity and weight-related medical issues. 'Obesity is a serious, chronic disease, and access to obesity medications should be treated with the same urgency as other chronic conditions,' Rhonda Pacheco, group vice president of U.S. Cardiometabolic Health at Lilly said in the press release. 'Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. In the meantime, the availability of the two highest-dose Zepbound vials gives providers and patients another important treatment option.' While the weight-loss drugs are popular with consumers, not so much with insurance companies, who don't always widely cover the drugs, leading Lily, and rival Novo Nordisk, the maker of Wegovy, to start offering their own self-pay options. The company first rolled out its self-pay, single-dose vials last summer in an effort to meet high consumer demand. Shares in the (NYSE: LLY) were trading down less than 2% at the market's close on Monday. Eli Lily: By the numbers In Eli Lily's latest round of earnings for the first quarter of 2025, ending March 31, 2025, the company showed a mixed performance, and reported net income of $2.76 billion and earnings per share (EPS) of $3.34, with revenue guidance between $58 billion and $61 billion. The drug maker has a market capitalization of $724.99 billion, as of this writing.
Business Insider
35 minutes ago
- Business Insider
Meta's AI app was full of accidental public posts that were really personal. It's now trying to fix that.
That delicate conversation about your wife, or a call for help about your daughter — or the weird pocket dial that recorded a conversation with your friend — are all less likely to accidentally end up on the public feed of Meta's AI app. Mark Zuckerberg's company is now giving users a new pop-up warning before they share something to Meta AI's "Discover" feed. This comes after Business Insider reported last week that the feed was full of personal information that appeared to have been accidentally shared — things like a post that showed a parent asking the AI for advice about a wayward daughter, the audio of a pocket dial where someone chatted to coworkers about their working hours, and the text of an employee seeking legal advice about their employer. Meta didn't respond to my request for comment Monday when I asked about the new pop-up. After BI's story last week, the BBC, The Washington Post, Wired, TechCrunch, and other media outlets ran their own stories on the apparently accidental oversharing. The new warning message, which was visible Monday, shows up after you hit "share" on a chat in the Meta AI app. The message says, "Prompts you post are public and visible to everyone. Your prompts may be suggested by Meta on other Meta apps. Avoid sharing personal or sensitive information." After that warning, the "Post to feed" button is disabled until you tap once more on the middle of the screen. Only then can you post to the public Discover feed. Meta AI's feed had eerily personal information Meta AI, the stand-alone AI chatbot, has its "Discover" feed for people to share images they created with AI or to post their chats with the bot. These chats aren't public by default; you've always had to click "share" and then "post" to send your chats to the Discover feed. Clearly, it seems some users didn't understand what they were doing under the previous system. (One man I talked to last week said he hadn't meant to post his conversation with the chatbot on car repair.) When the app first launched in late April, I wrote about the problem of accidental public posts on Meta AI. Checking back last week, I noticed that the problem seemed even worse — there were now way more posts that seemed to be clearly shared by mistake. Some of these included intimate personal issues, like asking for help drafting a letter to a judge about child custody, medical issues, and relationship quandaries. People on X also found examples of people posting tax information, or seeming not to even understand what they were using, like a person who asked what would happen if they put a deep heat cream on their private parts, but then asked the bot to keep the conversation private (on a public feed). Hmm. Meta AI's new pop-up warns people before posting Now, of course, it's entirely possible that some of these embarrassing purient posts were secretly intentional. (The person who asked Meta AI to make him a variety of images of celebrities doing strange things, including Ana de Armas tucking Spider-Man into bed, may have wanted people to see his stuff.) Another change in the Discover feed on Meta AI I noticed on Monday: It's now almost exclusively images. Last week, and the times I'd checked in on the app since it began in late April, the feed had a hefty peppering of text- and audio-based posts, like those seemingly accidental pocket dials. Meta also didn't respond to BI if the apparent tweak to the Discover feed was intentional — like if things other than images have been buried or disappeared — or if the change is a potential natural consequence of the new extra tap needed to share something to the public feed. Or if it's something else altogether. I'll update this story if Meta gets back to me, but for now, I'm glad I don't have to close my eyes, or cringe, or flinch (as much) when I scroll through the Meta AI Discover feed.
